Merrimack Pharmaceuticals (NASDAQ:MACK)

CAPS Rating: 3 out of 5

Recs

0
Player Avatar 10cent (97.40) Submitted: 1/14/2013 4:03:15 PM : Outperform Start Price: $6.19 MACK Score: +1.40

biotech speculation. trade pick.

Featured Broker Partners


Advertisement